Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells

Fig. 4

Quantitative characterization of the hematopoietic stem/progenitor cell (HSPC) populations after a 7-day expansion in a co-culture system with mesenchymal stromal cells from different sources. a Percentage of hematopoietic stem/progenitor (CD34+ cells), more primitive (CD34+CD90+) and progenitor T cells (CD34+CD7+) before and after expansion. b Fold increase of hematopoietic stem/progenitor (CD34+ cells), more primitive (CD34+CD90+) and progenitor T cells (CD34+CD7+) after expansion. c Percentage of cell populations with myeloid potential before and after expansion. AT, adipose tissue; BM, bone marrow; FBS, fetal bovine serum; FI, fold increase; FL, feeder layer; HPL, human platelet lysate; UCM, umbilical cord matrix. n = 3 for all conditions, with exception of ‘NO FL’: n = 2. Values are presented as mean ± SEM. **p < 0.01; *p < 0.05 (statistical significance is only showed for FBS conditions)

Back to article page